{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:11:39Z","timestamp":1789506699610,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971909"],"award-info":[{"award-number":["81971909"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1303503"],"award-info":[{"award-number":["2022YFA1303503"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128841","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:47:59Z","timestamp":1781657279000},"page":"128841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Booster vaccine reduces BCG-primed mice's protection against primary Mycobacterium tuberculosis infection by raising IL-10 levels"],"prefix":"10.1016","volume":"88","author":[{"given":"Qing","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinge","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengze","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xionglin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128841_bb0005","author":"WHO"},{"key":"10.1016\/j.vaccine.2026.128841_bb0010","doi-asserted-by":"crossref","first-page":"e1655","DOI":"10.1016\/S2214-109X(19)30444-9","article-title":"Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study","volume":"7","author":"Roy","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128841_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG world atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.128841_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007462","article-title":"Tracking changes in national BCG vaccination policies and practices using the BCG world atlas","volume":"7","author":"Lancione","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2026.128841_bb0025","doi-asserted-by":"crossref","first-page":"e1220","DOI":"10.1016\/S2214-109X(22)00325-4","article-title":"Infant BCG vaccination is beneficial, but not sufficient","volume":"10","author":"Hatherill","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128841_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2018.00121","article-title":"Next-generation vaccines based on Bacille Calmette-Gu\u00e9rin","volume":"9","author":"Nieuwenhuizen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05683-w","article-title":"Early introduction of IL-10 weakens BCG revaccination\u2019s protection by suppressing CD4+Th1 cell responses","author":"Lei","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.vaccine.2026.128841_bb0040","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.vaccine.2012.02.036","article-title":"Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis","volume":"30","author":"Brennan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128841_bb0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128841_bb0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128841_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-019-0113-9","article-title":"Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques","volume":"4","author":"Darrah","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.128841_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ebiom.2017.07.005","article-title":"A multistage subunit vaccine effectively protects mice against primary progressive tuberculosis, latency and reactivation","volume":"22","author":"Ma","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2026.128841_bb0065","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3389\/fimmu.2018.02439","article-title":"Heterologous boost following Mycobacterium bovis BCG reduces the late persistent, rather than the early stage of intranasal tuberculosis challenge infection","volume":"9","author":"Wu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0070","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01(E) vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128841_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.946181","article-title":"IL-10 overexpression after BCG vaccination does not impair control of Mycobacterium tuberculosis infection","volume":"13","author":"Ferreira","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0080","article-title":"Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-\u03b3+ IL-2+ CD4+ and IFN-\u03b3+ CD8+ T cells","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128841_bb0085","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1080\/21645515.2015.1037057","article-title":"Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine","volume":"11","author":"Teng","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128841_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575504","article-title":"Combinational PRR agonists in liposomal adjuvant enhances immunogenicity and protective efficacy in a tuberculosis subunit vaccine","volume":"11","author":"Hao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2018.00310","article-title":"Formulation in DDA-MPLA-TDB liposome enhances the immunogenicity and protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection","volume":"9","author":"Tian","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M. tuberculosis infection","volume":"4","author":"Redford","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0105","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.4049\/jimmunol.0803567","article-title":"Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity","volume":"183","author":"Schreiber","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179701","article-title":"Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages","volume":"12","author":"Chatterjee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128841_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150060","article-title":"Early IL-10 promotes vasculature-associated CD4+ T cells unable to control Mycobacterium tuberculosis infection","volume":"6","author":"Ferreira","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2026.128841_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/cmi.2018.5","article-title":"Constitutive STAT3 phosphorylation and IL-6\/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients","volume":"16","author":"Harling","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0125","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.201040433","article-title":"Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung","volume":"40","author":"Redford","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.167.3.1535","article-title":"Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination","volume":"167","author":"Silva","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0135","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.1201061","article-title":"Blockade of IL-10 signaling during bacillus Calmette-Gu\u00e9rin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-\u03b3 and IL-17 responses and increases protection to Mycobacterium tuberculosis infection","volume":"189","author":"Pitt","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0140","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4049\/jimmunol.2100900","article-title":"IL-10 receptor blockade delivered simultaneously with Bacillus Calmette-Gu\u00e9rin vaccination sustains long-term protection against Mycobacterium tuberculosis infection in mice","volume":"208","author":"Dwivedi","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0145","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1128\/IAI.71.12.6871-6883.2003","article-title":"The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10","volume":"71","author":"Huard","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128841_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124134","article-title":"Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting","volume":"10","author":"Belay","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128841_bb0155","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/21691401.2018.1438450","article-title":"Cationic DDA\/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity","volume":"46","author":"Qu","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smim.2018.10.003","article-title":"Immunocorrelates of CAF family adjuvants","volume":"39","author":"Pedersen","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/jphp.12390","article-title":"Correlating liposomal adjuvant characteristics to in-vivo cell-mediated immunity using a novel Mycobacterium tuberculosis fusion protein: a multivariate analysis study","volume":"67","author":"Kastner","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.05.019","article-title":"The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production","volume":"154","author":"Henriksen-Lacey","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2026.128841_bb0175","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128841_bb0180","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1089\/aid.2013.0076","article-title":"Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-Bissau","volume":"29","author":"Rom\u00e1n","year":"2013","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.vaccine.2026.128841_bb0185","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.4049\/jimmunol.174.8.5007","article-title":"In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin is due principally to trehalose mycolates","volume":"174","author":"Geisel","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0190","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1099\/mic.0.28158-0","article-title":"Intact molecular characterization of cord factor (trehalose 6,6\u2032-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry","volume":"151","author":"Fujita","year":"2005","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.vaccine.2026.128841_bb0195","first-page":"371","article-title":"Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease","volume":"36","author":"Hunter","year":"2006","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.vaccine.2026.128841_bb0200","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajpath.2019.10.006","article-title":"Mycobacterial Trehalose 6,6\u2019-Dimycolate-induced M1-type inflammation","volume":"190","author":"Nguyen","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.trsl.2010.06.001","article-title":"Lactoferrin modulation of mycobacterial cord factor trehalose 6-6\u2032-dimycolate induced granulomatous response","volume":"156","author":"Welsh","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.vaccine.2026.128841_bb0210","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.4049\/jimmunol.180.11.7404","article-title":"The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans","volume":"180","author":"Wells","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20081445","article-title":"Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation","volume":"206","author":"Werninghaus","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2026.128841_bb0220","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1084\/jem.20091750","article-title":"Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle","volume":"206","author":"Ishikawa","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2026.128841_bb0225","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128841_bb0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tube.2017.02.003","article-title":"Variable BCG efficacy in rhesus populations: pulmonary BCG provides protection where standard intra-dermal vaccination fails","volume":"104","author":"Verreck","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2026.128841_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128841_bb0240","article-title":"Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection","volume":"2","author":"Dijkman","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.vaccine.2026.128841_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004603","article-title":"Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization","volume":"11","author":"Gideon","year":"2015","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600650X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600650X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:40:38Z","timestamp":1789504838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600650X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":49,"alternative-id":["S0264410X2600650X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128841","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Booster vaccine reduces BCG-primed mice's protection against primary Mycobacterium tuberculosis infection by raising IL-10 levels","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128841"}}